Grazoprevir and Elbasvir in Patients with Genotype 1 Hepatitis C Virus Infection: A Comprehensive Efficacy and Safety Analysis

Background. It is urgent for patients with hepatitis C virus (HCV) infection to find a safe, effective, and interferon-free regimen to optimize therapy. A comprehensive analysis was performed to evaluate the efficacy and safety of the grazoprevir combined with elbasvir, with or without ribavirin (RB...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yinan, Yue, Ming, Wang, Jie, Chen, Hongbo, Liu, Mei, Zang, Feng, Li, Jun, Zhang, Yun, Huang, Peng, Yu, Rongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253517/
https://www.ncbi.nlm.nih.gov/pubmed/28164081
http://dx.doi.org/10.1155/2017/8186275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253517/
https://www.ncbi.nlm.nih.gov/pubmed/28164081
http://dx.doi.org/10.1155/2017/8186275

Ejemplares similares